
<h3>BIBLIOGRAFÍA</h3>

    <ol>
        <li>Lillicrap D. Molecular testing for disorders of hemostasis. Int J Lab Hematol 2013;35:290-6.</li>
        <li>Huang LH, Lin PH, Tsai KW, et al. The effects of storage temperature and duration of blood samples on DNA and RNA qualities. PLoS One 2017;12:e0184692.</li>
        <li>Dasi MA, González-Conejero R, Izquierdo S, Padilla J, Garcia JL, García Barberá N, et al. Uniparental disomy causes deficiencies of vitamin K-dependent proteins. J Thromb Haemost 2016;14:2410-8.</li>
        <li>De la Morena-Barrio ME, Martínez-Martínez I, de Cos C, Wypasek E, Roldán V, Undas A, et al. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect. J Thromb Haemost 2016;14:1549-60.</li>
        <li>Peyvandi F, Kunicki T, Lillicrap D. Genetic sequence analysis of inherited bleeding diseases. Blood 2013;122:3423-31.</li>
        <li>Westrick RJ, Ginsburg D. Modifier genes for disorders of thrombosis and hemostasis. J Thromb Haemost 2009;7(Suppl 1):132-5.</li>
        <li>Martinelli I, De Stefano V, Mannucci PM. Inherited risk factors for venous thromboembolism. Nat Rev Cardiol 2014;11:140-56.</li>
        <li>Germain M, Chasman DI, de Haan H, Tang W, Lindström S, Weng LC, et al. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet 2015;96:532-42.</li>
        <li>Schwartz MLB, Williams MS, Murray MF. Adding Protective Genetic Variants to Clinical Reporting of Genomic Screening Results: Restoring Balance. JAMA 2017;317:1527-8.</li>
        <li>Pasi KJ, Rangarajan S, Georgiev P, Mant T, Creagh MD, Lissitchkov T, et al. Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy. N Engl J Med 2017;377:819-28.</li>
        <li>Corral J, Iniesta JA, González-Conejero R, Villalón M, Vicente V. Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 2001;97:2979-82.</li>
        <li>Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis. N Engl J Med 2015;372:232-40.</li>
    </ol>